Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pediatric Relapsed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05334823
What this trial is testing

PCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents

Who this might be right for
Acute Lymphoblastic LeukemiaRelapsed Pediatric ALLRefractory Acute Lymphoblastic Leukemia
Chongqing Precision Biotech Co., Ltd 100
Early research (Phase 1)Ended earlyNCT02676323
What this trial is testing

Panobinostat With Fludarabine and Cytarabine for Treatment of Children With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
St. Jude Children's Research Hospital 19
Early research (Phase 1)Study completedNCT02793466
What this trial is testing

Durvalumab in Pediatric and Adolescent Patients

Who this might be right for
Solid TumorLymphomaCentral Nervous System Tumors
Leo Mascarenhas 15
Early research (Phase 1)Study completedNCT01523977
What this trial is testing

Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL

Who this might be right for
Acute Lymphoblastic Leukemia
Dana-Farber Cancer Institute 22
Early research (Phase 1)Study completedNCT00002912
What this trial is testing

Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia

Who this might be right for
Leukemia
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Study completedNCT00038207
What this trial is testing

Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies

Who this might be right for
Soft Tissue SarcomaLymphomaLeukemia+2 more
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)UnknownNCT02638428
What this trial is testing

Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy

Who this might be right for
Relapsed Pediatric Solid TumorRefractory Pediatric Solid TumorRelapsed Pediatric AML+1 more
Samsung Medical Center 90
Early research (Phase 1)Study completedNCT03236857
What this trial is testing

The Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies

Who this might be right for
MalignanciesAcute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)+2 more
AbbVie 143
Early research (Phase 1)Active Not RecruitingNCT04106219
What this trial is testing

LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Eli Lilly and Company 71
Testing effectiveness (Phase 2)Study completedNCT01088984
What this trial is testing

Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute Leukemia

Who this might be right for
Leukemia
Teva Branded Pharmaceutical Products R&D, Inc. 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07660172
What this trial is testing

Ianalumab in Addition to Eltrombopag in Pediatric Patients With Primary ITP Who Failed Corticosteroids.

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Novartis Pharmaceuticals 36
Large-scale testing (Phase 3)Study completedNCT02393859
What this trial is testing

Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Leukemia, Acute Lymphoblastic
Amgen 111
Early research (Phase 1)Looking for participantsNCT05188170
What this trial is testing

Niclosamide in Pediatric Patients With Relapsed and Refractory AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Stanford University 16
Testing effectiveness (Phase 2)Study completedNCT04238819
What this trial is testing

Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Who this might be right for
Relapsed Solid TumorRefractory Solid Tumor
Eli Lilly and Company 47
Testing effectiveness (Phase 2)Looking for participantsNCT04544592
What this trial is testing

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaB-cell Non Hodgkin Lymphoma
University of Colorado, Denver 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT05071209
What this trial is testing

Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors

Who this might be right for
Recurrent Alveolar RhabdomyosarcomaRecurrent Ewing SarcomaRecurrent Lymphoma+5 more
National Cancer Institute (NCI) 31
Early research (Phase 1)Study completedNCT04833582
What this trial is testing

Azenosertib (ZN-c3) in Combination With Gemcitabine in Subjects With Osteosarcoma

Who this might be right for
Osteosarcoma
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc 31
Not applicableUnknownNCT05983341
What this trial is testing

Complications in Pediatric Mechanical Circulatory Assistance: Evaluation of Infection Management.

Who this might be right for
Heart FailureImplant Infection
Hospices Civils de Lyon 50
Early research (Phase 1)Study completedNCT01528046
What this trial is testing

Metformin in Children With Relapsed or Refractory Solid Tumors

Who this might be right for
Solid TumorsPrimary Brain Tumors
H. Lee Moffitt Cancer Center and Research Institute 26
Testing effectiveness (Phase 2)Looking for participantsNCT06941272
What this trial is testing

Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

Who this might be right for
Malignant Neoplasm
Merck Sharp & Dohme LLC 50
Next Page